BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26463431)

  • 1. A human papillomavirus (HPV)-16 or HPV-18 genotype is a reliable predictor of residual disease in a subsequent hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia 3.
    Kang WD; Ju UC; Kim SM
    J Gynecol Oncol; 2016 Jan; 27(1):e2. PubMed ID: 26463431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
    Kang WD; Kim SM
    Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of residual disease in hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia grade 3.
    Wu Q; Jiang Y; Ding J; Xia L; Xu H
    BMC Pregnancy Childbirth; 2022 Dec; 22(1):971. PubMed ID: 36575366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual lesions in uterine specimens after loop electrosurgical excision procedure in patients with CIN.
    Jing L; Dan W; Zhunan L; Ying X; Yi C
    Arch Gynecol Obstet; 2018 Oct; 298(4):805-812. PubMed ID: 30167855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.
    Du R; Meng W; Chen ZF; Zhang Y; Chen SY; Ding Y
    Eur J Gynaecol Oncol; 2013; 34(6):548-51. PubMed ID: 24601049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.
    Park JY; Lee SM; Yoo CW; Kang S; Park SY; Seo SS
    Gynecol Oncol; 2007 Oct; 107(1):39-44. PubMed ID: 17582476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
    Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
    Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
    Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure.
    Kang WD; Oh MJ; Kim SM; Nam JH; Park CS; Choi HS
    Am J Obstet Gynecol; 2010 Jul; 203(1):72.e1-6. PubMed ID: 20417477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
    Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization].
    Niu XY; Feng YK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):321-5. PubMed ID: 25924452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
    Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
    Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus test after conization in predicting residual disease in subsequent hysterectomy specimens.
    Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Obstet Gynecol; 2009 Jul; 114(1):87-92. PubMed ID: 19546763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
    BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
    Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
    Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
    Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Residual/Recurrent Disease and Its Risk Factors after Loop Electrosurgical Excision Procedure for High-Grade Cervical Intraepithelial Neoplasia.
    Wu J; Jia Y; Luo M; Duan Z
    Gynecol Obstet Invest; 2016; 81(4):296-301. PubMed ID: 26337009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
    Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure.
    Bae JH; Kim CJ; Park TC; Namkoong SE; Park JS
    Int J Gynecol Cancer; 2007; 17(6):1271-7. PubMed ID: 17442018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.